GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Becton, Dickinson and Co (NYSE:BDXB.PFD) » Definitions » Other Net Income (Loss)

Becton, Dickinson and Co (Becton, Dickinson and Co) Other Net Income (Loss) : $-46.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Becton, Dickinson and Co Other Net Income (Loss)?

Becton, Dickinson and Co's Other Net Income (Loss) for the three months ended in Mar. 2024 was $0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was $-46.00 Mil.

Becton, Dickinson and Co's quarterly Other Net Income (Loss) increased from Sep. 2023 ($-45.00 Mil) to Dec. 2023 ($-1.00 Mil) and increased from Dec. 2023 ($-1.00 Mil) to Mar. 2024 ($0.00 Mil).

Becton, Dickinson and Co's annual Other Net Income (Loss) declined from Sep. 2021 ($488.00 Mil) to Sep. 2022 ($144.00 Mil) and declined from Sep. 2022 ($144.00 Mil) to Sep. 2023 ($-46.00 Mil).


Becton, Dickinson and Co Other Net Income (Loss) Historical Data

The historical data trend for Becton, Dickinson and Co's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Becton, Dickinson and Co Other Net Income (Loss) Chart

Becton, Dickinson and Co Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Other Net Income (Loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 522.00 488.00 144.00 -46.00

Becton, Dickinson and Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.00 - -45.00 -1.00 -

Becton, Dickinson and Co Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-46.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Becton, Dickinson and Co Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Becton, Dickinson and Co's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Becton, Dickinson and Co (Becton, Dickinson and Co) Business Description

Address
1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of estimated 2023 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.

Becton, Dickinson and Co (Becton, Dickinson and Co) Headlines